What to look for this week on Contemporary OB/GYN®
You can expect a variety of topics to be covered this week on Contemporary OB/GYN®, including:
Curbside Consults delivers expert perspectives from physicians outside of the ob/gyn specialty to provide insight into various health issues affecting pregnant women, about which they are experts. This new section is the brainchild of Editorial Advisory Board member Christine Isaacs, MD.
Being named in a lawsuit, however, does not always mean a medical error was made. Most claims are dropped, dismissed, or withdrawn, and trials are often won by the physician. Take a look back at the year’s top cases and see how each one unfolded.
A case study on diagnosis and management. Could you recognize this rare condition?
Join Senior Editor Angie DeRosa with a look back at this year's cover designs and feature stories.
Pembrolizumab plus lenvatinib induced a statistically significant and clinically meaningful improvement in overall survival, progression-free survival, and objective response rate compared with chemotherapy in patients with advanced endometrial cancer after prior systemic therapy in the phase 3 KEYNOTE-775/Study 309 trial.
Check back soon for additional updates.